Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate LS Corp. Strong Buy (bullish), based on 8 analysts. Average price target: ₩535,250.
Top signal score 10 of 100
Buys €502M€42M Sells
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 19,326 of 26,304 companies
35.5
score / 100
Value
43
Quality
28
FCF yld-17%
Earn yld4.6%
EV/EBITDA10.2x
ROE9.4%
Gross mgn8.9%
Net mgn0.8%
Debt/EBITDA6.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
LS Corp., a South Korean group classed as chemicals with a market capitalisation of KRW 6,276.3 billion, has a record in which most filings are not market trades: of 90 filings published between February 26, 2021 and July 2, 2026, 76 are of another kind. The record counts 5 purchases, only one with an amount, and 9 sales, only one with an amount: EUR 882,481, by 구자열, on March 3, 2026.
구자열, filed as 대량보유자, is the most frequent with 47 filings, 4 of them sales. 국민연금공단, classed 10%이상주주, has 32, with 4 purchases and 4 sales. Ls appears 8 times with no open-market trade, and 삼성자산운용 once, with a purchase.
Read moreShow less
The 6 filers hold 33.1% of the capital. The yearly pace falls: 30 filings in 2021 and 24 in 2022, then 10 in 2023 and 7 in both 2025 and 2026. The last twelve months hold 9 filings, 2 purchases and 2 sales. The median publication delay is 4 days.